Chinese Stocks Rally As Beijing Goes All-In On Financial Support, Squeezes Short Sellers
Chinese equities surge on government's plans to inject 2 trillion yuan and restrict short selling, signaling potential market recovery.
Why Are Tencent And NetEase Shares Up Today? Hint: It Has To Do With Chinese Goverment Gaming Regulations
China's gaming regulator has removed proposed rules from its website that aimed at curbing spending and rewards in video games.
Pro-Crypto Sen. Cynthia Lummis Claps Back At Sen. Elizabeth Warren: ‘Crypto Is Clearly Not The Problem’
U.S. Sen. Cynthia Lummis (R-Wyo.) rebuffed Sen. Elizabeth Warren's (D-Mass.) claim that crypto is used for nefarious purposes.
What’s Going On With Alibaba And Chinese Peer Stocks Tuesday?
Alibaba (BABA) stock rises with Chinese market as peers PDD, BIDU, and JD also join rally. China plans $278 billion stimulus to support stock market.
Roomba Maker iRobot Struggles with Potential EU Rejection of Amazon Acquisition and Falling Sales, Analyst Says
IRobot (NASDAQ: IRBT) stock fell to 52-week lows as EU regulators may reject Amazon's planned acquisition. Analyst expects $94M if deal breaks.
Nvidia’s Key Market China Wants To Beat US Embargo, Boosts Chipmaking Machinery Imports by 14%
China's chip imports surged 14% to $40B in 2023 despite a 5.5% decline in total imports. This reflects efforts to boost national capabilities amid US sanctions on advanced chipmaking machinery and China's establishment of a $40B state fund for chip industry.
Why Is Alibaba Stock Trading Lower Monday?
Alibaba stock drops with broader indexes due to China's economic struggles. Other Chinese stocks also see significant declines. BABA shares down 3.17%.
Alphabet’s Waymo Set To Transform LA’s Transport With Robotaxi Fleet Amid Regulatory Complexities
Waymo has been executing tests with its autonomous white Jaguars in Los Angeles for approximately a year.
CORRECTION FDA Accepts Autolus Therapeutics’ Marketing Application For Obecabtagene Autoleucel For Relapsed/Refractory Adult B-cell Acute Lymphoblastic Leukemia, With Target Action Date Of November 16, 2024
Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the U.S.
Elon Musk Slammed For Wanting More Tesla Control, Rivian Skids On Prospect Of Significant Losses, Fisker Faces Braking Issue Probe And More: Biggest EV Stories Of The Week
EV stock investors have turned extremely cautious ahead of the reporting season, as the industry is facing a slowdown.